INTRODUCTION
============

Gallstone disease (GSD) is a common gastrointestinal disease with a spectrum of clinical presentations from asymptomatic silent gallstones to severe acute cholecystitis. The prevalence is reported to be 10%--15% in adults with risk factors including old age, female gender, obesity, metabolic syndrome, and chronic liver disease.[@b1-gnl-13-114] Gallstones with or without cholecystitis are one of the most common reasons for hospital admission, and treatment by laparoscopic cholecystectomy has become more popular in recent years. The burden of GSD has increased in recent years, with direct and indirect costs of the disease estimated to be more than \$6.2 billion in the United States.[@b2-gnl-13-114],[@b3-gnl-13-114]

Notwithstanding that alcohol consumption is a known risk factor for many chronic diseases and malignancies,[@b4-gnl-13-114]--[@b6-gnl-13-114] there have been many clinical epidemiological studies regarding the negative correlation between alcohol consumption and GSD risk. Thereafter, two meta-analyses revealed that alcohol consumption has a preventive effect on the development of GSD,[@b7-gnl-13-114],[@b8-gnl-13-114] and Wang *et al*.[@b8-gnl-13-114] presented a linear relationship with a 12% risk reduction with each 10 g/day increment of alcohol (relative ratio \[RR\], 0.88; 95% confidence interval \[CI\], 0.84 to 0.92) in a dose-response meta-analysis. This systematic review was carried out to define the optimal level of alcohol consumption to maximize the protective effect on GSD.

MATERIALS AND METHODS
=====================

Two authors (B.H.C. and M.J.J.) performed a comprehensive systematic search for published studies that aimed to evaluate the relationship between alcohol consumption and GSD risk.

1. Search methods to identify studies
-------------------------------------

A comprehensive, systematic search was conducted for published articles from database inception to March 01, 2018 using MEDLINE, EMBASE, and Cochrane Controlled Trials Register. We confined our search to only English publications. The MEDLINE search strategy was adapted for use in the other databases searched ([Appendix 1](#s1-gnl-13-114){ref-type="supplementary-material"}). The reference lists of retrieved articles were also examined for additional, eligible studies.

2. Selection criteria
---------------------

Studies were included if they met the following criteria: (1) cohort or case-control studies published as original articles (abstracts, letters, reviews, and meta analyses were excluded); (2) studies reporting the relative risks (odds ratio \[OR\], RR, or hazard ratio \[HR\]) between alcohol consumption and GSD or sufficient data to calculate them. Case-control studies were excluded if drinking categories were based on alcohol consumption at the time of interview.[@b9-gnl-13-114] When studies with overlapping populations were identified, the most appropriate study for this comparison was selected in terms of bias. When additional information was required, we contacted the corresponding authors of the study.

3. Data extraction
------------------

Data extraction was completed by two authors (B.H.C. and M.J.J.) independently from all included studies with a predefined information sheet, in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses).[@b10-gnl-13-114] Any discrepancies in extracted data were resolved through consensus or discussion with a third author (S.H.L.). The following information was taken from each article: publication year, country, study design, sample size, age, gender, endpoint definition (cholelithiasis, GSD, cholecystitis, or cholecystectomy from calculous cholecystitis), the number of cases and controls or number of events and subjects at risk/person-years, risk ratio estimates with 95% CIs, and covariates adjusted in the statistical analysis. The adjusted RRs were extracted and when they were not available, and unadjusted RRs and 95% CIs were extracted or calculated.

4. Quality assessment
---------------------

The overall study quality was assessed independently by two authors (B.H.C. and M.J.J.) using the Newcastle-Ottawa Scale (NOS) for case-control and cohort studies.[@b11-gnl-13-114] The NOS consists of three domains: selection (four items, one star each), comparability (one item, up to two stars), and outcome (three items, one star each). Nine stars on the NOS reflects the highest quality. Studies with a NOS score of 7 to 9 and less than 7 were considered to have a low and high risk of bias, respectively. Any disagreements between the reviewers were resolved through discussion ([Appendix 2](#s1-gnl-13-114){ref-type="supplementary-material"}).

5. Statistical analysis
-----------------------

The association between alcohol consumption and the risk of GSD was examined on the basis of the pooled relative risks and their 95% CIs. For the pooling analysis, alcohol consumption was converted into grams of ethanol per day using the standard drink size provided by the study or the conversion factors (0.8 g/mL, 28.35 g/oz, 14 g/drink, and 7.9 g/unit). The drinking level for each RR was assigned as the median or mean amount (in grams) of alcohol intake in each exposure category. When the median or mean intake per category was not reported, the midpoint of the upper and lower boundaries in each category was given. For the open-ended upper boundary, a value of 1.2 times the lower boundary was assigned to the category.[@b12-gnl-13-114] For the open-ended lower boundary, the lower boundary was assumed to be zero. Nondrinking was considered as the reference category. There are several published guidelines defining moderate, heavy and binge drinking levels according to standard drinking definition: 1--2 drinks/day (7--14 g/day), more than 2 drinks/day (\>14 g/day), and 4--5 drinks/day (28--35 g/day).[@b13-gnl-13-114]--[@b15-gnl-13-114] Based on those criteria, we classified consumption into light, moderate and high drinking as follows: \<7, 7--14, and \>14 g/day for women and \<14, 14--28 and \>28 g/day for men, respectively. For the studies in which the lowest category included both non-drinking and light drinking, the lowest category was used as the reference category. If there was more than one RR for each drinking category defined for this study, the study-specific risk estimates were combined with the Hamling *et al*.[@b16-gnl-13-114] if the numbers of cases and person-years or numbers for each nondrinking and drinking group were available or calculable; otherwise, the data were pooled with inverse variance weighting. For study-specific RR for overall drinking compared to nondrinking, the RR was estimated by pooling all RRs for the drinking categories defined in each study using the same method as described above. For the study reporting RR per drinking unit, RR for overall drinking was estimated by the RR at the mean or median drinking unit in the study, as the power of RR by the mean or median value. When raw data were available, all necessary RRs were obtained from analysis of the raw data. For the association of alcohol consumption and risk of GSD, pooled RRs among studies and their 95% CIs and p-values were calculated using the random-effects model. Statistical heterogeneity between the studies was assessed with Cochran Q-test and I^2^ statistics. I^2^ values of 25%, 50% and 75% have been suggested to be indicators of low, moderate, and high heterogeneity, respectively.[@b17-gnl-13-114] Subgroup analysis was performed on study design and participant sex. Heterogeneity between subgroups was assessed using Cochran Q-test. Funnel plots and Egger tests for asymmetry were applied to assess the possibility of publication bias among the studies. To examine the dose-response association between alcohol consumption and GSD risk, 2-stage, random-effects, dose-response meta-analyses were performed.[@b18-gnl-13-114],[@b19-gnl-13-114] First, a study-specific restricted cubic spline model with four knots at the fixed 5th, 35th, 65th, and 90th percentiles of alcohol consumption levels was estimated using generalized least square regression accounting for the correlation between estimates within each study. Second, study-specific estimates were pooled using the restricted maximum likelihood method in a random-effects meta-analysis. A p-value for nonlinearity was calculated by testing the null hypothesis that the regression coefficients of the spline transformations are all equal to zero. The predicted RR of alcohol intake was estimated based on the linear or restricted cubic splines. Statistical analyses were performed using STATA version 12.0 (Stata Corporation, College Station, TX, USA) or R version 3.4.1 (The R Foundation for Statistical Computing, Vienna, Austria). Two-sided p-values \<0.05 were considered to be statistically significant.

RESULTS
=======

1. Description of studies
-------------------------

In total, 190 articles were identified as relevant by an initial search strategy, and 47 duplicated cases were removed ([Fig. 1](#f1-gnl-13-114){ref-type="fig"}). One hundred and twenty-six articles were excluded during screening for eligibility due to unmatched enrollment criteria. Finally, 17 articles that met the inclusion criteria were selected. The article of Thijs *et al*.[@b20-gnl-13-114] had four case-control studies (studies A, B1, B2, and B3). Among the four studies, study A was not included for this meta-analysis because its cases or controls overlapped those of the other two studies (studies B1 and B3), and the study design was more susceptible to protopathic bias than the other studies were. Of these, three articles (Scragg *et al*.,[@b21-gnl-13-114] Rhodes and Venables,[@b22-gnl-13-114] Banim *et al*.[@b23-gnl-13-114]) reported the effects of drinking by gender, in one study by Cha *et al*.,[@b24-gnl-13-114] the effects by gender were calculated from raw data, and one article[@b25-gnl-13-114] reported the sex-adjusted effects in both sex groups and the effects for females only. Lastly, a total of 24 studies (16 case-control studies and 8 cohort studies) were included in this meta-analysis study.

The summary of baseline characteristics is described in [Table 1](#t1-gnl-13-114){ref-type="table"}.[@b20-gnl-13-114]--[@b36-gnl-13-114] In total, 24,401 patients with gallstones and 76,185 controls were estimated from 16 case-control studies, and 14,693 cases of GSD developed among 2,432,471 person-years in eight cohort studies. Among the 24 enrolled studies, six reported their estimates in female-only groups, another four in male-only groups, and the other 14 studies reported data on both sex groups. The majority of selected studies were performed in the USA and Europe, while four were in Asia, and one was in Australia. Each study provided adjusted risk measurements regarding different confounding factors.

2. Quality of the included studies
----------------------------------

The NOS scores of the 24 included studies ranged from 6 to 9 stars ([Appendixes 2 and 3](#s1-gnl-13-114){ref-type="supplementary-material"}). Eight of the 24 studies had a NOS score of 9, seven studies had a score of 8, where scores of 8 were given to seven studies because two studies used self-report for ascertainment of exposure (zero stars in assessment of exposure), and five studies controlled for important factors (only one star in comparability domain). Three studies were scored as 7, with no stars in items of representativeness of study population, ascertainment of outcome or exposure, since their study populations were health professionals, nurses or twins; two studies used self-report for ascertainment of outcome, and the other had no description of ascertainment of exposure. One study was rated as 6 stars since it used self-report for ascertainment of exposure and outcome in nurses.

3. Categorical meta-analysis
----------------------------

### 1) Overall drinking compared to nondrinking

The pooled RR of GSD for alcohol drinking compared to non-drinking was 0.84 (95% CI, 0.79 to 0.89; I^2^=61%) based on 23 studies; only one of these studies included sex-adjusted effects for both sex groups ([Fig. 2](#f2-gnl-13-114){ref-type="fig"}).[@b25-gnl-13-114] The subgroup analyses by study design showed that there was a significant difference between study designs (p=0.02). The pooled analysis from case-control studies showed a greater decreased effect of drinking than that found in cohort studies. The pooled RR from studies with a cohort design was 0.89 (95% CI, 0.84 to 0.89) with low heterogeneity between studies (I^2^=28%), and the pooled RR from studies with a case-control design was 0.74 (95% CI, 0.63 to 0.86) with large heterogeneity (I^2^=70%). The pooled RRs by sex were 0.79 (95% CI, 0.66 to 0.95; I^2^=65%) for females and 0.69 (95% CI, 0.51 to 0.93; I^2^=68%) for males, with no significant difference between sex (p=0.46) ([Fig. 3](#f3-gnl-13-114){ref-type="fig"}).

### 2) Drinking categories compared to nondrinking

Pooled analysis revealed that every alcohol consumption category was significantly associated with a decreased risk of GSD, with greater decreased risk in the higher alcohol consumption groups ([Fig. 4](#f4-gnl-13-114){ref-type="fig"}). The pooled RRs for the light, moderate and high alcohol consumption groups compared to those in the non-drinking groups were 0.96 (95% CI, 0.94 to 0.99; I^2^=0%), 0.80 (95% CI, 0.75 to 0.85; I^2^=17%) and 0.66 (95% CI, 0.56 to 0.79; I^2^=61%), respectively. The high alcohol consumption groups showed the greatest decreased risk of GSD with significantly large heterogeneity between studies. In the subgroup analysis by study design, the pooled effects of moderate and high alcohol consumption in case-control studies were larger than those in cohort studies ([Fig. 5](#f5-gnl-13-114){ref-type="fig"}).

4. Dose-response meta-analysis
------------------------------

The dose-response meta-analysis of 14 studies suggested a nonlinear relationship between alcohol consumption and risk of GSD from 14 studies (p=0.002 for nonlinearity) ([Fig. 6](#f6-gnl-13-114){ref-type="fig"}). The risk of GSD decreased with increasing alcohol consumption up to approximately 30 g/day, and the decrease in risk plateaued above 30 g/day. The RRs (95% CIs) of GSD compared to non-drinking groups were 0.92 (0.89 to 0.95), 0.82 (0.79 to 0.85), 0.67 (0.64 to 0.71), and 0.62 (0.58 to 0.66), and 0.61 (0.52 to 0.71) for 7, 14, 28, 40, and 60 g/day of alcohol consumption, respectively. However, the dose-response results by study design showed that the nonlinear relationship between alcohol consumption and the risk of GSD was statistically significant in case-control studies but not in cohort studies (p=0.001 and p=0.184 for nonlinearity in case-control and cohort studies, respectively).

5. Publication bias
-------------------

Funnel plots and Egger's tests for overall drinking suggested significant asymmetry (Egger test p=0.009) ([Fig. 7](#f7-gnl-13-114){ref-type="fig"}). However, no significant asymmetries were found by alcohol consumption categories (Egger tests p=0.383, p=0.523, and p=0.602 for low-, moderate-, and high-consumption categories, respectively).

DISCUSSION
==========

To estimate the association of alcohol consumption and GSD risk, we performed this meta-analysis of 16 case-control and eight cohort studies and found a significant dose-dependent, risk-reduction effect of drinking alcohol as a result (RR, 0.84; 95% CI, 0.79 to 0.89).

There were two published meta-analyses regarding the correlation between alcohol consumption and gallstone development risk.[@b7-gnl-13-114],[@b8-gnl-13-114] One meta-analysis found no significant correlation between alcohol consumption and incidental gallstone risks.[@b7-gnl-13-114] Another meta-analysis showed a statistically significant, inverse relationship between the highest and lowest consumption categories (RR, 0.62; 95% CI, 0.49 to 0.78), whose pooled risk reduction was larger than that of the overall drinking data relative to nondrinking or to the lowest category in this meta-analysis.[@b8-gnl-13-114]

Mechanisms underlying the protective effect of alcohol against gallstone formation have been explained in several ways: (1) decreased cholesterol saturation;[@b37-gnl-13-114]--[@b39-gnl-13-114] (2) increased high-density lipoprotein by reduction of cholesteryl ester transfer protein;[@b40-gnl-13-114]--[@b43-gnl-13-114] and (3) increased gallbladder motility.[@b44-gnl-13-114]--[@b46-gnl-13-114]

To discover the optimum level of alcohol drinking, we extracted quantitative alcohol consumption amounts with individual risk estimates in each category or continuous variables from each study and then sorted those data into new three categories: light, moderate, and high consumption. From the results, we obtained each different pooled RR according to the increment of alcohol consumption: 0.96 (0.94 to 0.99) in the light group; 0.80 (0.75 to 0.85) in the moderate group; 0.66 (0.56 to 0.79) in the high group. Furthermore, we carried out a dose-response meta-analysis for overall consumption and each subgroup of study design and sex. The RRs for GSD showed a weak trend between 28 and 40 g/day with a plateau occurring above 40 g/day, with RRs of 0.62 (0.58 to 0.66) and 0.61 (0.52 to 0.71) at 40 and 60 g/day, respectively. The dose-response relationship in case-control studies showed the same tendency as the overall group did, whereas a steady linear decline in RR for GSD was demonstrated in cohort studies, in which only two of the six studies had a drinking level of over 30 g/day.

Contrast to the former meta-analysis, we summarized the risk estimations measured by daily alcohol consumption according to standardized categories, which was comparable to different alcohol types based on the recommended statistical methods.[@b12-gnl-13-114],[@b16-gnl-13-114],[@b17-gnl-13-114] Secondarily, we discovered a trend of linear decline in GSD risk according to an increase in alcohol consumption and a weakened linear trend between 28 and 40 g/day compared to that of under 28 g/day in the overall and case-control studies but not in the cohort studies. The previous meta-analysis included one Asian study, which was completed in Thailand. We enrolled three more articles published in Asia (2 Chinese and 1 Korean), but two of them were cross-sectional studies; therefore, we included one more case-control study from Asia.[@b24-gnl-13-114]

There were limitations in our study. Although we achieved a nonlinear trend shown in the dose-response analysis among the overall studies and case-control studies, the same trend was not found among the cohort studies, which have the highest level of evidence. We attempted to enroll more studies published in various countries, for example, Asia, Africa, and South America; however, the majority of studies included for the dose-response meta-analysis were performed in North America and Europe due to newly published Asian studies having lower levels of evidence. Meanwhile, it was quite difficult to compare the quantitative alcohol effects in various beverage types and among the diverse individuals who are drinking in different ways, for example, in frequency and amount. Therefore, more important studies from varied regions and more comparable standardization methods are warranted to generalize the conclusions from our study.

In addition to the above limitations, clinicians need to be cautious in recommending drinking for the purpose of GSD prevention because excessive drinking, defined as binge drinking, and chronic heavy alcohol consumption results in multiple psychiatric and clinical illnesses, including mortality from a variety of chronic diseases.[@b47-gnl-13-114]--[@b50-gnl-13-114]

In conclusion, we confirmed that alcohol drinking decreases the risk of GSD development based on our meta-analysis of case-control and cohort studies. There was a linear risk reduction and weakened linear trend between consumption levels below and above 28 g/day in the dose-response analysis.

Supplementary Material
======================

Authors contributions: Two authors (B.H.C. and M.J.J.) performed a comprehensive systematic search for published studies which aimed to evaluate the relationship between alcohol consumption and gallstone disease risk. Data extraction was completed by two authors (B.H.C. and M.J.J.) independently from all included studies with a predefined information sheet, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses.[@b44-gnl-13-114] Any discrepancies in extracted data were solved through consensus or discussion with a third author (S.H.L.). The overall study quality was assessed independently by two authors (B.H.C. and M.J.J.) using the Newcastle--Ottawa Scale (NOS).
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###### 

Relative risks (RRs) of alcohol consumption for gallstone disease development based on alcohol drinking categories (light, moderate, and high) among case-control and cohort studies. Drinking level for each category: light, F\<7 and M\<14 g/day; moderate, F 7--17 and M 14--18 g/day; high, F\>14 and M\>28 g/day.

CI, confidence interval; F, female; M, male, B, both.
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![Dose-response relationship between alcohol consumption and gallstone disease risk. (A) All included studies (n=14), p for nonlinearity \<0.001. (B) Case-control study (n=8), p for nonlinearity=0.001. (C) Cohort study (n=6), p for nonlinearity=0.1839.](gnl-13-114f6){#f6-gnl-13-114}
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###### 

Baseline Characteristics of Studies Included in the Meta-Analysis (n=24)

  Study                                             Design                          Region              Outcome measures                                                        Sex, age (yr)              Case/total      Alcohol (unit)                        Alcohol category (g/day)   Alcohol category (L/M/H)   RR (95% CI)                                                    Adjusted confounders                                                                                                                                                                                                                                                                                                                                                                                                                          NOS
  ------------------------------------------------- ------------------------------- ------------------- ----------------------------------------------------------------------- -------------------------- --------------- ------------------------------------- -------------------------- -------------------------- -------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----
  La Vecchia *et al*. (1991)[@b26-gnl-13-114]       CC                              Italy               Cholelithiasis or cholecystitis undergone, Cholecystectomy, Interview   Both, 21--74               195/1,317       0 (drinks/day)                        0                          Ref                        1                                                              Age, sex, area of residence, smoking, coffee, history of liver disease, BMI                                                                                                                                                                                                                                                                                                                                                                   9
                                                                                                                                                                                                                           1--3                                  28                         M                          0.8 (0.6--1.3)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                           \>3                                   67.2                       H                          0.5 (0.3--0.8)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Kato *et al*. (1992)[@b27-gnl-13-114]             Cohort                          Hawaiian Japanese   Cholelithiasis and/or cholecystitis, Interview                          Male, ≥45                  461/7,716       Nondrinker (oz/mo)                    0                          Ref                        1                                                              Age                                                                                                                                                                                                                                                                                                                                                                                                                                           8
                                                                                                                                                                                                                           \<4.7                                 2.2                        L                          1.0 (0.8--1.3)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                           4.7--24.6                             13.8                       M                          1.0 (0.7--1.2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                           ≥24.7                                 28                         H                          0.8 (0.6--1.0)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Grodstein *et al*. (1994)[@b28-gnl-13-114]        Cohort                          US                  Symptomatic gallstones, Self-administrated questionnaire                Female (nurse), 25--42     425/96,211      0 (g/day)                             0                          Ref                        1                                                              Age, oral contraceptive use, postmenopausal hormone use, BMI, weight change, parity, cigarette smoking                                                                                                                                                                                                                                                                                                                                        6
                                                                                                                                                                                                                           0.1--4.9                              2.5                        L                          0.8 (0.7--1.0)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                           5--14.9                               10                         M                          0.8 (0.6--1.0)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                           ≥15                                   18                         H                          0.7 (0.4--1.4)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Leitzmann *et al*. (1999)[@b29-gnl-13-114]        Cohort (Health professionals)   US                  Gallstone diseases, Self-administrated FFQ                              Male, 40--75               1,081/46,006    0 (g/day)                             0                          Ref                        1                                                              Age, BMI, weight change, physical activity, history of diabetes mellitus, pack-years of smoking, coffee consumption, intake of cholesterol-lowering drugs, thiazide diuretics, NSAlDs, energy-adjusted dietary, energy-adjusted carbohydrates                                                                                                                                                                                                 7
                                                                                                                                                                                                                           0.1--1.4                              0.8                        L                          0.97 (0.76--1.22)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           1.5--4.9                              3.2                        L                          0.95 (0.79--1.14)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           5.0--14.9                             10                         L                          0.83 (0.69--0.99)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           15.0--29.9                            22.5                       M                          0.75 (0.60--0.93)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           30+                                   36                         H                          0.64 (0.50--0.81)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Leitzmann *et al*. (2003)[@b30-gnl-13-114]        Cohort (nurse)                  US                  Cholecystectomy, Self-administrated FFQ                                 Female, 30--55             7,831/80,898    0 (g/day)                             0                          Ref                        1                                                              Time period, age, BMI, weight change, oral contraceptive use, hormone replacement therapy, physical activity, history of diabetes mellitus, pack-years of smoking, use of thiazide diuretics, energy-adjusted fiber intake, energy-adjusted carbohydrate intake, energy-adjusted polyunsaturated fat intake, coffee intake                                                                                                                    7
                                                                                                                                                                                                                           0.1--4.9                              2.5                        L                          0.95 (0.89--1.00)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           5.0--14.9                             10                         M                          0.86 (0.80--0.93)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           15.0--29.9                            22.5                       H                          0.8 (0.72--0.89)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                           30.0--49.9                            40                         H                          0.67 (0.57--0.78)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           ≥50                                   60                         H                          0.62 (0.49--0.79)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Banim *et al.* (2011)[@b23-gnl-13-114]            Cohort                          UK                  Symptomatic gallstone disease, Self-administrated questionnaire         Female, 40--74             201/1,3075      0 (g/day)                             0                          Ref                        1                                                              Age, hormone replacement therapy, parity                                                                                                                                                                                                                                                                                                                                                                                                      7
                                                                                                                                                                                                                           0.11--7.9                             4                          L                          1.01 (0.70--1.46)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           7.9--15.8                             11.9                       M                          0.72 (0.42--1.24)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           15.8--23.7                            19.8                       H                          0.99 (0.48--2.05)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           23.7                                  28.4                       H                          1.10 (0.39--3.11)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Banim *et al*. (2011)[@b23-gnl-13-114]            Cohort                          UK                  Symptomatic gallstone disease, Self-administrated questionnaire         Male, 40--74               95/11,188       0 (g/day)                             0                          Ref                        1                                                              Age, physical activity, BMI                                                                                                                                                                                                                                                                                                                                                                                                                   8
                                                                                                                                                                                                                           0.11--7.9                             4                          L                          1.10 (0.58--2.14)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           7.9--15.8                             11.9                       L                          1.20 (0.58--2.46)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           15.8--23.7                            19.8                       M                          0.58 (0.21--1.58)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           23.7                                  28.4                       H                          0.46 (0.17--1.25)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Bodmer *et al*. (2011)[@b31-gnl-13-114]           CC (matched)                    UK                  Cholecystectomy, Not reported on alcohol survey                         Both, ≥20                  22,574/95,050   0 (units/wk)                          0                          Ref                        1                                                              Age, sex, BMI, general practice, years of history in the database, and calendar time by matching, smoking, a history of ischemic heart disease, congestive heart failure, and hypertension, use of statins, use of oral contraceptives (females only)                                                                                                                                                                                         8
                                                                                                                                                                                                                           1--7                                  4.5                        L                          0.98 (0.95--1.02)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           8--14                                 12.4                       M                          0.80 (0.75--0.85)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           15--29                                24.8                       M                          0.68 (0.62--0.74)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           30+                                   40.6                       H                          0.53 (0.46--0.62)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Misciagna *et al*. (1999)[@b32-gnl-13-114]        CC (matched)                    Italy               Gallstone, Self-administrated FFQ                                       Both, 0--69                100/390         0 (g/day)                             0                          Ref                        1                                                              Age, sex, BMI, energy, energy, protein, saturated fat, monounsaturated fat, polyunsaturated fat, cholesterol, glycogen, refined sugar, fiber from cellulose, fiber from noncellulose, calcium                                                                                                                                                                                                                                                 9
                                                                                                                                                                                                                           0.1--15.6                             7.9                        L                          0.83 (0.39--1.78)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           15.6--38.5                            27.1                       M                          0.74 (0.32--1.67)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           ≥38.5                                 46.2                       H                          0.42 (0.14--1.28)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Cha *et al*. (2017)[@b24-gnl-13-114]              CC                              Korea               Symptomatic GBS, Interview                                              Female, 16--92             73/143          0 (g/day)                             0 (median)                 Ref                        1                                                              Age, hypertension, diabetes mellitus, BMI                                                                                                                                                                                                                                                                                                                                                                                                     9
                                                                                                                                                                                                                           7--14                                 8.1                        M                          0.38 (0.06--2.35)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           ≥14                                   32.3                       H                          0.11 (0.02--0.53)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Cha *et al*. (2017)[@b24-gnl-13-114]              CC                              Korea               Symptomatic GBS, Interview                                              Male, 16--88               97/193          0                                     0                          Ref                        1                                                              Age, hypertension, diabetes mellitus, vascular occlusive disease, obesity                                                                                                                                                                                                                                                                                                                                                                     9
                                                                                                                                                                                                                           7--28                                 16.1                       M                          0.30 (0.1--0.85)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                           ≥28                                   64.6                       H                          0.29 (0.11--0.78)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Thijs *et al*. (1991)[@b20-gnl-13-114] Study B1   CC                              Nether- land        Acute gallstone, Disease, Interview                                     Both                       151/602         0 (drinks/day)                        0                          Ref                        1                                                              Age, sex, coffee use, smoking, pregnancies, duration of oral contraceptive use, duration of perimenopausal sex hormone use, diabetes mellitus, BMI, skipping breakfast, sedentary life style, sporting activities, slimming courses, age at menarche, number of years postmenopausal, cholesterol-lowering drug use, long-term daily analgesic use, parents with gallstones, brothers with gallstones, sisters with gallstones, interviewer   9
                                                                                                                                                                                                                           \<1                                   7                          L                          1.1 (0.5--2.28)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                           1--2                                  21                         M                          0.7 (0.32--1.6)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                           3--7                                  70                         H                          1.5 (0.63--3.4)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Thijs *et al*. (1991)[@b20-gnl-13-114] Study B2   CC                              Netherland          General hospital, Population, Interview                                 Both                       63/852          0 (drinks/day)                        0                                                     1                                                              Age, sex, coffee use, smoking, pregnancies, duration of oral contraceptive use, duration of perimenopausal sex hormone use, diabetes mellitus, BMI                                                                                                                                                                                                                                                                                            9
                                                                                                                                                                                                                           \<1                                   7                          L                          0.9 (0.42--2.01)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                           1--2                                  21                         M                          1 (0.45--2.07)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                           3--7                                  70                         H                          1 (0.36--2.6)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Thijs *et al*. (1991)[@b20-gnl-13-114] Study B3   CC                              Netherland          Radiologic screening, Interview                                         Both                       77/352          0 (drinks/day)                        0                          Ref                        1                                                              Age, sex, coffee use, smoking, pregnancies, duration of oral contraceptive use, duration of perimenopausal sex hormone use, diabetes mellitus, BMI                                                                                                                                                                                                                                                                                            9
                                                                                                                                                                                                                           \<1                                   7                          L                          0.9 (0.38--2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                           1--2                                  21                         M                          0.6 (0.29--1.39)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                           3--7                                  70                         H                          1.5 (0.43--5.39)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Katsika *et al*. (2007)[@b33-gnl-13-114]          Cohort (twin)                   Sweden              Symptomatic GBS, Self-administrated questionnaire                       Both                       1,666/58,402    0 (g/day)                                                        Ref                        1                                                              Sex, BMI, alcohol, smoking and smoke-free tobacco                                                                                                                                                                                                                                                                                                                                                                                             7
                                                                                                                                                                                                                           0.1--60 (F), 0.1--80 (M)              (L, M, H)                  \-                         0.93 (0.83--1.04)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                           \>60 (F), \>80 (M)                    \(H\)                      \-                         0.57 (0.49--0.67)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Shabanzadeh *et al*. (2017)[@b34-gnl-13-114]      Cohort                          Denmark             Gallstones or cholecystectomy, Self-administrated questionnaire         Both, 30--60               256/2,848       Unit/wk                               \-                         \-                         0.94 (0.89--1.00)[\*](#tfn2-gnl-13-114){ref-type="table-fn"}   Age, sex, and BMI                                                                                                                                                                                                                                                                                                                                                                                                                             8
  Scragg *et al*. (1984)[@b21-gnl-13-114]           CC (matched)                    Australia           FFQ interview                                                           Female, \<70               176/352         Drinking                                                                                    0.51 (0.34--0.78)[†](#tfn3-gnl-13-114){ref-type="table-fn"}    Sex, age, residential area, sugar in drinks and sweets, total fat, interaction between fat and age, cholesterol                                                                                                                                                                                                                                                                                                                               9
                                                                                                                                                                                Male, \<70                 57/114                                                                                                      0.24 (0.08--0.73)[†](#tfn3-gnl-13-114){ref-type="table-fn"}    Sex, age, residential area, sugar in drinks and sweets, energy, interaction between energy and age                                                                                                                                                                                                                                                                                                                                            9
  Halldestam *et al*. (2009)[@b35-gnl-13-114]       Cohort                          Sweden              Self-administrated questionnaire                                        Both, 35--85               42/503          ≥1/wk                                                                                       0.29 (0.09--0.98)                                              Age, sex, follow-up interval, BMI, heredity of gallstone, skilled current or previous occupation, smoking, NSAID intake, diabetes mellitus, HDL, LDL, TG, lipoprotein A                                                                                                                                                                                                                                                                       8
  Panpimanmas and Manmee (2009)[@b25-gnl-13-114]    CC                              Thailand            Self-administrated questionnaire                                        Both                       207/407         Nondrinkers                                                                                 1                                                              Age, sex, BMI, smoking history, fat content in dietary meat, diabetes mellitus                                                                                                                                                                                                                                                                                                                                                                8
                                                                                                                                                                                                                           \<5 yr                                                                                      1.0 (0.5--2.2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                           5--10 yr                                                                                    1.2 (0.6--2.4)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                           \>10 yr                                                                                     0.8 (0.4--1.9)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Panpimanmas and Manmee (2009)[@b25-gnl-13-114]    CC                              Thailand            Self-administrated questionnaire                                        Female                     132/274         Nondrinkers                                                                                 1                                                              Age, BMI, fat content in dietary meat, diabetes mellitus, no of children, duration of contraceptive use                                                                                                                                                                                                                                                                                                                                       8
                                                                                                                                                                                                                           \<5 yr                                                                                      1.1 (0.4--3.1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                           5--10 yr                                                                                    1.9 (0.6--5.7)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                           \>10 yr                                                                                     1.0 (0.4--2.6)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Rhodes and Venables (1991)[@b22-gnl-13-114]       CC                              UK                  Cholecystectomy, Self-administrated questionnaire                       Female, 25--92 (mean=59)   178/356         Regular drinking (mean=6 units/wk)                                                          0.72 (0.47--1.1)                                               Age and sex (matched)                                                                                                                                                                                                                                                                                                                                                                                                                         8
  Rhodes and Venables (1991)[@b22-gnl-13-114]       CC                              UK                  Cholecystectomy, Self-administrated questionnaire                       Male, 33--85 (mean=64)     69/138          Regular drinking (mean=23 units/wk)                                                         0.29 (0.07--0.91)                                              Age and sex (matched)                                                                                                                                                                                                                                                                                                                                                                                                                         8
  Kato *et al*. (1990)[@b36-gnl-13-114]             CC                              Japan               Self-administrated questionnaire                                        Both, ≥30                  86/202          Daily drinking                                                                              1.97 (0.8--4.82)                                               Age, sex and residence                                                                                                                                                                                                                                                                                                                                                                                                                        7

L, light; M, moderate; H, high; RR, relative risk; CI, confidence interval; NOS, Newcastle-Ottawa Scale; CC, case-control; BMI, body mass index; FFQ, food frequency questionnaire; NSAIDs, nonsteroidal anti-inflammatory drugs; GBS, gallbladder stone; M, male; F, female; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride.

OR for median drinking=0.99[@b6-gnl-13-114](0.98[@b6-gnl-13-114], 1.00[@b6-gnl-13-114]) calculated with OR=0.99 (0.98, 1.00) for 1 unit/week and median drinking of 6 units/week;

OR for mean drinking calculated with one-unit OR estimates reported and mean drinking of 4 g and 11g for females and males, respectively.

[^1]: Byung Hyo Cha and Myoung-jin Jang contributed equally to this work as first authors.
